Who invested in Pear Therapeutics?
Pear Therapeutics's investors include 5AM Ventures, EDBI, Novartis, Arboretum Ventures and Jazz Venture Partners, and 8 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$239Mraised across 4 rounds since 2015, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by BusinesswireSEC filing: $46M sold, first sale Dec 2017
Reported by FinSMEs
From the SEC filings it signed: 7 on the team.
On the board, as filediAndrew SchwabTimothy PetersenZack Lynch
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Pear Therapeutics's investors include 5AM Ventures, EDBI, Novartis, Arboretum Ventures and Jazz Venture Partners, and 8 more on record.
Pear Therapeutics has raised $239M across 4 rounds since 2015. One round did not disclose an amount, so the total is a floor.
Pear Therapeutics's most recent round was an Undisclosed round of $125M in Dec 2021.
Its most recent round, $125M in Dec 2021, is also its largest on record.
Pear Therapeutics's first round on record, in Mar 2015, was backed by 5AM Ventures.
Pear Therapeutics's latest named round is an Undisclosed round, in Dec 2021.
Pear Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.